主动脉弓病变病理对0区分支胸主动脉腔内弓部修复术结局的影响
本研究比较慢性主动脉夹层(C-AD)与非主动脉夹层(N-AD)病因患者接受0区分支胸主动脉腔内弓部修复术(Z0BTEVAR)的结局。2011至2023年三个欧洲中心共213例,N-AD组复合结局(院内死亡与致残性卒中)高于C-AD组(15.7% vs 5.4%,P=0.01),术后卒中更多(17.7% vs 4.5%,P<0.01)。既往A型主动脉夹层对复合结局有保护作用(OR 0.2,95%CI 0.1-0.6),累及0或1区的退行性动脉瘤预测术后卒中(OR 3.7,95%CI 1.2-11.8)。
要点
- N-AD组复合结局高于C-AD组(15.7% vs 5.4%,P=0.01)。
- N-AD组术后卒中多于C-AD组(17.7% vs 4.5%,P<0.01)。
- 4年生存率N-AD组71.8%±6.6% vs C-AD组71.5%±6.5%(P=0.81)。
核心结论
- Z0BTEVAR可用于高危患者并获得满意的短期和中期结局,尤其是既往夹层患者;患者选择重要,应继续努力减少术后卒中。
研究设计与样本
- 2011至2023年三个欧洲中心接受Z0BTEVAR的慢性主动脉夹层(C-AD)或非主动脉夹层(N-AD)病因患者共213例,其中C-AD组111例、N-AD组102例,中位年龄72岁。
主要发现
- 总体复合结局(院内死亡与致残性卒中)为10.3%,N-AD组高于C-AD组(15.7% vs 5.4%;P=0.01)。
- N-AD组术后卒中多于C-AD组(17.7% vs 4.5%;P<0.01)。
- 多变量分析中,既往A型主动脉夹层对复合结局有保护作用(OR 0.2;95%CI 0.1-0.6)。
- 累及0或1区的退行性动脉瘤预测术后卒中(OR 3.7;95%CI 1.2-11.8)。
- 4年生存率N-AD组为71.8%±6.6%,C-AD组为71.5%±6.5%(P=0.81)。
临床怎么用
- 作者认为Z0BTEVAR可用于高危患者并获得满意的短期和中期结局,尤其是既往夹层患者;患者选择重要,应继续努力减少术后卒中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Zone 0 branched thoracic endovascular arch repair (Z0BTEVAR) has emerged as an alternative to open repair for high-risk patients with aortic arch pathology. However, it is unclear how disease characteristics in this population impacts clinical outcomes. The study aimed to compare Z0BTEVAR according to arch disease pathology and to identify potential predictors of postoperative outcomes. METHODS: From 2011 to 2023, patients who underwent Z0BTEVAR for chronic aortic dissection (C-AD) or for non-aortic dissection (N-AD) etiology at three European centers were included. The primary outcome was a composite of in-hospital mortality and disabling stroke. Multivariable logistic analyses were conducted to identify independent predictors of the outcomes. RESULTS: Overall, 213 patients underwent Z0BTEVAR, including 111 patients treated for C-AD and 102 patients treated for N-AD. The median age was 72 years old. Overall composite outcome was 10.3%, higher for patients with N-AD compared with patients with C-AD (15.7% vs 5.4%; P = .01). Similarly, patients with N-AD had more postoperative strokes (17.7% vs 4.5%; P < .01). On multivariable analysis, previous type A aortic dissection was protective for the composite outcome (odds ratio, 0.2; 95% confidence interval, 0.1-0.6), whereas degenerative aneurysm with zone 0 or 1 involvement was predictive of postoperative stroke (odds ratio, 3.7; 95% confidence interval, 1.2-11.8). At 4 years, survival for the N-AD group was 71.8% ± 6.6%, and for the C-AD group was 71.5% ± 6.5% (P = .81). CONCLUSION: Z0BTEVAR could be performed with satisfactory short- and mid-term outcomes for high-risk patients, particularly those with previous dissection. Patient selection is important, and continued effort should be placed on minimizing postoperative stroke.
引用
- Guo MH, Kölbel T, Le Houerou T, et al. Impact of arch disease pathology on outcomes of zone 0 branched thoracic endovascular arch repair. J Vasc Surg. 2024. PMID: 39694156. doi:10.1016/j.jvs.2024.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。